RFP A23-1484 Addendum 2 with attachments.pdf

Ames National Laboratory is operated by Iowa State University for the U.S. Department of Energy.

ADDENDUM NO. 2

TO

DATE OF Addendum:

7/20/2023

REQUEST FOR PROPOSAL NO. RFP A23-1484 Spedding Hall Room 10 Remodel Project

SENT VIA EMAIL

The purpose of this addendum to RFP is to:

1. Replace Appendix A1 with the updated and most current version. (See Attached)

2. Change rev on Appendix A1 on RFP doc under 13. Appendices

Notes:

• There were no questions submitted which require answers.

• Wynn Jones will be the supplier of the case work and cabinetry so this will remain as noted in the

Contractor Requirements, Appendix B.

ALL OTHER TERMS AND CONDITIONS OF THE SOLICITATION REMAIN UNCHANGED.

Please direct all questions to:

Ames National Laboratory Procurement Representative

Andrew Saxton Contract Manager 515-294-4191 saxton@ameslab.gov

COVID-19 Workplace Safety Plan 10200.246 Revision 2.0 Effective Date 06/02/2023 Contact Person Sean Whalen Review Date 06/01/2026

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

AMES NATIONAL LABORATORY COVID-19 WORKPLACE SAFETY FRAMEWORK

Table of Contents

1.0 CHANGE HISTORY

2.0 PURPOSE

3.0 SCOPE AND APPLICABILITY

4.0 GUIDING PRINCIPLES

5.0 COMMUNICATION

6.0 OPERATING STATUS

7.0 COVID-19 HOSPITAL ADMISSION LEVELS

8.0 HEALTH AND SAFETY PROTOCOLS – PEOPLE

8.1. Employee and Visitor COVID-19 Attestation, Screening, and Testing Protocol

8.2. Employee and Visitor Masking Protocol

8.3. Visitors – COVID-19 Specific Guidelines

8.4. High-risk Populations

8.5. Hygiene

8.6. Shared Spaces

8.7. Physical Distancing

8.8. Symptom Screening

8.9. Exposure, Post-Exposure, and Isolation

8.10. Management of On-site COVID-19 Cases

8.11. Confidentiality

9.0 HEALTH AND SAFETY PROTOCOLS – FACILITIES AND OPERATIONS

9.1. Construction Activities

9.2. Elevators

9.3. Emergency Actions

9.4. Meetings, Events, Conferences, and Travel

9.4.1. Meetings Events and Conferences

9.4.2. Travel

9.5. Dining/Vending Area

9.6. Ventilation and Air Filtration

10.0 APPROVAL RECORD

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

1.0 CHANGE HISTORY

Modifications to the Framework posted in ServiceNow reflect current guidelines and are effective upon date of approval.

On January 13, 2022, the Department of Energy (DOE) released revised guidance regarding the reentry timeline and implemented additional face covering requirements (subsequently relaxed). Those updates were included in revision 1.0.

• Revision 1.1 included additional reporting requirements for those who have tested positive for COVID-19 or been in close contact with someone who has. On February 28, 2022, the Safer Federal Workforce Task Force issued FAQs adopting revised Centers for Disease Control and Prevention (CDC) guidelines for community levels and mask-wearing.

• Revision 1.2: On March 8, 2022, DOE incorporated the task force recommendations via DOECAST, and the Laboratory included the modifications to its Framework in Revision 1.2.

• Revision 1.3 included updated meeting attendance guidance from DOE.

• Revision 1.4 reflected the adoption by DOE of CDC mask guidelines based on COVID Community Level.

• Revision 1.5 reflected the adoption by DOE of extensive changes outlined in the Safer Federal Workforce Task Force guidelines issued on August 17, 2022.

• Revision 1.6 included an extension to the review date.

• Revision 1.7 includes information published in the DOE COVID – 19 Workplace Safety Framework on 1/5/23, including updates to CDC guidance, and the inclusion of a more comprehensive Community Level Guidance Table.

• Revision 2.0 incorporates information published in the DOE COVID-19 Workplace Safety Framework on May 26, 2023, including modifications by DOE to implement protective protocols based on revised CDC transmission reporting derived from hospital admission levels and not community transmission rates.

2.0 PURPOSE

The health and safety of the Ames National Laboratory workforce, subcontractors, visitors, and the public is the Laboratory’s highest priority. Ames Laboratory and the DOE are committed to ensuring employee safety in the workplace consistent with best public health practices. The Laboratory’s paramount concern is the health and safety of all individuals. Given this, the Laboratory may implement COVID-19 mitigation measures that go beyond recommended CDC guidance.

As set forth in the January 20, 2021, Executive Order 13991 “Protecting the Federal Workforce and Requiring Mask-Wearing,” the policy of the Administration is “to halt the spread of coronavirus disease 2019 (COVID-19) by relying on the best available data and science-based public health measures”. This Framework has been developed in accordance with relevant orders and guidance, including: the Office of Management and Budget (OMB) memorandum M-21-15, COVID-19 Safe Federal Workplace: Agency Model Safety Principles, issued January 24, 2021; OMB memorandum M-21-25, Integrating Planning for a Safe Increased Return of Federal Employees and Contractors to Physical Workplaces with Post-Reentry Personnel Policies and Work Environment, issued June 10, 2021; Safer Federal Workforce Task Force COVID-19 Workplace Safety: Agency Model Safety Principles, updated September 15, 2022;, and relevant court orders; guidance from the Safer Federal Workforce Task Force; updated U.S. Centers for

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

Disease Control and Prevention (CDC) guidance; Occupational Safety and Health Administration (OSHA) guidelines; and other Federal guidance.

This Framework outlines the requirements to protect the health and safety of the workforce in DOE facilities and for the safe accomplishment of the DOE and Laboratory mission in a COVID-19 environment. The Framework is a living document that will be updated as needed to account for changing COVID-19 conditions, Safer Federal Workforce Task Force guidance, Exceptions, and CDC guidance.

*NOTE: While some aspects of the Federal requirements remain under litigation, the requirements outlined in this framework are considered current and enforceable.

3.0 SCOPE AND APPLICABILITY

Version 1.8 of this Framework replaces all previous versions of the Ames National Laboratory COVID-19 Health and Safety Plan and provides overall Ames Laboratory and DOE requirements and guidance for the development of necessary site/facility plans. The Laboratory will update site/facility plans as appropriate to ensure compliance with this overarching COVID-19 Workplace Safety Framework.

The safety principles in this Framework document apply to Federal employees, contractors, and persons entering or working at Ames Laboratory facilities. The principles presented here establish a minimum level for workplace safety and are aligned with current CDC guidance and established public health best practices, based on evolving understanding of the pandemic. These principles will be reassessed over time, as conditions warrant. This document is not meant to be exhaustive, and additional program or site/facility controls will be developed as needed. The Ames Laboratory Safety Framework will build upon these principles and be tailored as appropriate for mission requirements and facility status.

The principles and timeframes in this Framework document apply to Ames Laboratory personnel. The Laboratory, and ISU, if applicable, will satisfy collective-bargaining and labor-management relations obligations before finalizing site/facility reentry plans. Site/Facility safety plans will discuss specific protocols and will be reviewed by the Ames Site Office (AMSO).

4.0 GUIDING PRINCIPLES

• We will protect the health and welfare of employees and their families, students, visitors, subcontractors, and collaborators.

• We will ensure the safety and security of Laboratory personnel, facilities, and equipment as we conduct operations.

• The Laboratory will continue to support flexible work arrangements consistent with established policies and procedures to ensure employees feel safe remotely or on-site

• We will provide clear and transparent communication with Laboratory, ISU, and DOE personnel regarding COVID related actions, activities, and decisions.

5.0 COMMUNICATION

Communication of on-going recovery and workplace safety activities is critical for enhancing staff confidence. It is also crucial to ensure staff employ operational changes designed to protect health and limit disease spread and understand the criteria for off-site and on-site work, their role in maintaining safe and healthy interactions, and the importance of preventing a resurgence of infections which may cause further disruptions. Information must be provided regularly to ISU and DOE regarding Laboratory status.

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

• Communications will be delivered to Laboratory staff through Director’s Messages, the Insider, ESH Newsletter, email, virtual or in-person all-hands meetings, and the Laboratory website.

Posters and flyers may also be utilized to reinforce messaging.

• Communication targeting infection mitigation strategies (hand washing, physical distancing, wearing of face coverings, reporting symptoms, and vaccinations) will be provided to staff.

• Information will be shared frequently with ISU, AMSO representatives, and other DOE entities as requested.

• Postings and signage describing the current COVID-19 hospital admissions level and corresponding safety protocols will be maintained at the primary entrances to Laboratory buildings.

6.0 OPERATING STATUS

The Laboratory, at the direction of DOE, has relaxed the requirement for maximum telework. All Laboratory staff are authorized to return on-site.

7.0 COVID-19 HOSPITAL ADMISSION LEVELS

The CDC has replaced COVID-19 Community Levels with COVID-19 Hospital Admission Levels, which measure the impact of COVID-19 illness on health and healthcare systems and inform the appropriate prevention strategies to utilize at a given time. CDC provides county-level data showing the COVID-19 Hospital Admission Levels for each county in the United States, as determined by CDC.

In applying COVID-19 workplace safety protocols connected to levels of hospital admissions, such as masking and social distancing, in a given area, Ames Laboratory will reference the CDC COVID-19 by County Levels. The Laboratory is located in Story County.

Ames Laboratory assesses admission rates in a given area at least weekly to determine proper requirements. The level in Story County (LOW, MEDIUM, or HIGH) dictates protocols (described in table below), which are consistent with CDC guidelines and guidance from the DOE and Safer Federal Workforce Task Force and are implemented as soon as operationally feasible.

https://www.cdc.gov/coronavirus/2019-ncov/your-health/covid-by-county.html https://www.cdc.gov/coronavirus/2019-ncov/your-health/covid-by-county.html

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

8.0 HEALTH AND SAFETY PROTOCOLS – PEOPLE

8.1. Employee and Visitor COVID-19 Attestation, Screening, and Testing Protocol There is no requirement for Ames Lab employees, visitors, or subcontractors to declare vaccination status, provide proof of a negative test, or complete a testing regime to access Ames Laboratory facilities, regardless of COVID-19 Hospital Admission Level.

Ames Laboratory staff are encouraged to test if symptomatic, or if they have been in close contact with an infected person. Test kits are available at a number of locations.

Staff are required to inform their supervisor and Occupational Medicine if they test positive for COVID-19.

Employees may contact the Occupational Medicine Office (om@ameslab.gov) for current information on testing options or where to be tested.

mailto:om@ameslab.gov

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

8.2. Employee and Visitor Masking Protocol

As has been the case throughout the pandemic, DOE and Ames Laboratory will take a measured, methodical approach in implementing actions to ensure safety for all personnel.

When masks are required, employees, contractors, and visitors must wear high-quality masks or respirators (e.g., surgical masks, N95s, KN95s): unfiltered cloth masks are not permitted.

Individuals may choose to wear a mask regardless of the COVID-19 Hospital Admission Level.

During HIGH levels, individuals entering Ames Laboratory spaces are required to wear a mask while in Ames Laboratory buildings and in leased space, including all public and work areas within a building (e.g., garages, hallways, snack bars, cafeterias, elevators, and restrooms). To ensure compliance, signage will be posted to inform individuals of the requirement, and the Laboratory website will be updated with the current Level.

In DOE buildings, wearing an unfiltered cloth mask is not acceptable unless it is worn over a surgical mask. Employees are urged to use KN-95 or N-95 masks. Surgical masks and KN-95 masks will be provided near entrances, elevators, in workspaces, and by request at the storeroom. Staff are reminded that KN-95s and N-95s are not single use and may be worn for an extended period until soiled or no longer properly fit. The N-95s and KN-95s are being provided as face coverings to reduce the potential for virus transmission and are not to be used as respiratory protection to perform work which requires the use of an N95 respirator as defined in a readiness review activity.

Novelty/non-protective masks, masks with ventilation valves, or face shields (except those provided with an additional barrier) are not considered an acceptable substitute for masks.

When masks are required, they must be worn in any common areas or shared workspaces (e.g., open floorplan office space, cubicle embankments, hallways, garages, conference rooms, or other workspaces) even when physically distant. Masks must also be worn outdoors in crowded settings or during outdoor activities that involve sustained close contact with other people.

When required, face masks must be worn in all in-person meetings and are required at convenient entry points. Plant Protection Officers may direct individuals to lower or temporarily remove their masks to verify identity. Additionally, when masks are required, employees must wear masks in Government-owned or operated vans, cars, trucks, and other motor pool passenger vehicles when multiple occupants are present.

Exceptions to wearing a mask for employees, when required, may include:

• Mask removal when alone in an office with floor-to-ceiling walls and the door shut;

• Mask removal when the sole occupant is in a Government-owned vehicle;

• Intermittent removal when eating/drinking -- masks may be removed for a limited time if one is at least six feet from another individual;

• Conducting work utilizing controls and/or personal protective equipment identified in a job hazards analysis or similar evaluation as long as the COVID-19 risk is factored into the analysis and the controls identified as part of that analysis are implemented;

• Conducting work where the hazards associated with wearing the mask (e.g., straps getting caught in machinery, heat stroke, etc.) are greater than the risks with not wearing a mask if the COVID-19 risk is factored into the job hazards analysis and the controls identified as part of that analysis are implemented; and

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

• Individuals who cannot wear masks due to medical or religious reasons. Exemptions to the face mask policy will be considered in accordance with existing Equal Employment Opportunity Commission (EEOC) and Iowa State University guidance. Federal employees will be required to go through the DOE Reasonable Accommodation process in order to seek an exemption.

8.3. Visitors – COVID-19 Specific Guidelines

Consistent with CDC guidance, onsite support service contractors and visitors are not required to show proof of a negative COVID-19 test when entering a DOE facility.

Visitors are discouraged from entering Ames Laboratory during HIGH Hospital Admission Levels.

If a visit is required, visitors and hosts must follow the Visitor Policy. If a visitor requires access, these actions will be met:

• The host is responsible for evaluating the visitor for wellness. Visitors demonstrating Influenza or COVID Like Illness (ILI or CLI) will be denied access.

• Visitors will be required to wear a face covering in the same locations as required for Ames Lab staff. If the visitor does not have their own face covering, one will be provided (available at ESH, Occ Med, or G34 TASF).

• The visitor must be escorted at all times. The host will ensure physical distancing and other Laboratory COVID safety procedures.

• If at any time during the visit the guest demonstrates Influenza Like Illness (ILI) or COVID Like Illness (CLI) they will be asked to leave the facility. If the host has been in close proximity, they will inform Occupational Medicine of potential exposure.

8.4. High-risk Populations

Staff who have elevated risk to significant impact by COVID-19 may discuss alterative work arrangements with their supervisor or Occupational Medicine to limit their potential exposure.

The supervisor will coordinate with Human Resources to review and discuss potential options for employees to safely perform their job duties and responsibilities.

8.5. Hygiene

Hand sanitizer stations and disinfectant wipes are available at building entrances and throughout workspaces. Sanitizer is FDA-approved and contains at least 60% ethanol. Personnel are encouraged to wash their hands with soap and water or use hand sanitizer or alcohol-based hand rubs frequently. To reinforce the importance of hygiene, signage is posted.

8.6. Shared Spaces

Shared tools and equipment should be cleaned by users anytime the equipment is used by or transferred to a new person. This includes phones, computers and other communication devices, kitchen implements, and other office equipment.

Refrigerators, water coolers, coffee brewers with disposable cups (or a personal re-usable cup/container), and single serve condiments and creamers may be used with proper hygiene.

In-person meetings are allowed, but staff may continue to take advantage of virtual meeting platforms whenever feasible. Staff meeting in person must follow all applicable guidelines described in this Framework.

https://now.ameslab.gov/sp?sysparm_article=KB0015849&id=kb_article_view&sysparm_rank=4&sysparm_tsqueryId=c20d9b081b8b2410994b859ce54bcb78

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

8.7. Physical Distancing

During periods of MEDIUM or HIGH Hospital Admission Levels, individuals are encouraged to consider physically distancing themselves from others and avoiding crowding in indoor common areas, meetings rooms, and elevators.

8.8. Symptom Screening

If Laboratory staff, subcontractors, or visitors are not feeling well, they are not to enter Laboratory facilities. Any individual who develops any symptoms consistent with COVID-19 during the workday must immediately isolate, notify their supervisor, and promptly leave the workplace.

Monitoring on-site or returning staff is essential to identify potential vectors and assure staff they are entering a safe work environment. While monitoring will not identify all potentially infectious persons, it is endorsed by medical professionals as an effective tool to reduce viral spread. If an employee has been exposed to COVID-19, it is important to take precautions, including wearing a high-quality mask for 10 full days from last exposure.

Daily Self-Checks: Employees are required to self-monitor for signs and symptoms of COVID-19 every day prior to coming to work. Symptom screening can be self-conducted and does not need to be verified by site/facility personnel. This includes monitoring for fever, cough, shortness of breath, and other COVID-19 related symptoms. If an employee experiences any symptoms, they should stay home and notify their supervisor and Occupational Medicine for further guidance.

Signage will be posted near multiple Lab entrances, emphasizing employees with symptoms should not enter the Laboratory and should contact Occupational Medicine for further guidance.

Public health and infection prevention recommendations will continue to be emphasized to ensure a safe working environment for employees including;

• It is the Laboratory’s expectation that staff stay home if they are sick

• Encouraging physical distancing (keeping at least 6-foot distance from others)

• Providing supplies that allow for frequent and thorough hand washing and hand sanitizing

• Providing and allowing use of acceptable face coverings (when practical) and other personal protective equipment

• Providing disinfectant supplies for regular cleaning of high traffic areas and other workspaces

• Providing opportunities for anyone who is high risk for more severe COVID-19 illness to continue to work remotely

• Vaccinations

Subcontractors, vendors, and construction personnel will not be allowed on-site unless they follow Ames Laboratory and their company’s COVID-19 safety procedures.

8.9. Exposure, Post-Exposure, and Isolation

Staff are required to inform their supervisor and Occupational Medicine if they test positive for COVID-19.

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

If an asymptomatic individual has a known exposure to someone with COVID-19, consistent with CDC recommendations, the individual is able to enter DOE sites/facilities or interact with members of the public in person as part of their official DOE responsibilities.

Pursuant to EO 13991 and consistent with Safer Federal Workforce Task Force and CDC guidance on postexposure precautions, individuals who are known to have been exposed to someone with COVID-19, regardless of their vaccination status, must:

• Wear a high-quality” mask or respirator (such as an N95) while indoors at a DOE site/facility or interacting indoors with members of the public in person as part of their official DOE responsibilities as soon as possible after notification of exposure and continue to do so for 10 full days from the date they were last known to have been exposed;

• Take extra precautions, such as avoiding crowding and physically distancing from others, when they know they are around people who are more likely to get very sick from COVID-19 while onsite at a DOE site/facility or interacting with members of the public in person as part of their official DOE responsibilities, for 10 full days from the date they were last known to have been exposed; and

• Watch for COVID-19 symptoms for 10 full days from the date they were last known to have been exposed.

For purposes of calculating the 10 full days, day 0 is the day of their last known exposure to someone with COVID-19, and day 1 is the first full day after their last known exposure.

As part of site/facility testing protocols, and pursuant to EO 13991 and consistent with CDC guidance, employees and contractor employees who are known to have been exposed to COVID-19 and are onsite at a DOE site/facility or interacting with members of the public in person as part of their official DOE responsibilities must be tested for current infection with a viral test at least 5 full days after their last known exposure (ideally, on or after day 6). The test can be both self-administered and self-read by the employee if the employee certifies as to when they took the test and that they received a negative result.

If the individual tests negative, then pursuant to EO 13991 and consistent with CDC guidance, the individual must continue to follow the above precautions for 10 full days from the date they were last known to have been exposed. If they test positive, or if they at any time develop COVID-19 symptoms, they must follow protocols on isolation.

If the individual that has been known to be exposed to COVID-19 is not working onsite at a DOE Site/Facility or interacting with members of the public in person as part of their official DOE responsibilities within 10 days of the known exposure, then they are not required to be tested.

If the individual who has been known to be exposed to COVID-19 has already tested positive for COVID-19 with a viral test within the previous 30 days and subsequently recovered and remains without COVID-19 symptoms, then they do not need to get tested after a known exposure. If the individual who had been known to be exposed to COVID-19 has already tested positive for COVID-19 with a viral test within the previous 31-90 days and subsequently recovered and remains without COVID-19 symptoms, then they should be tested using a viral antigen test.

Isolation and Post-Isolation Precautions https://www.cdc.gov/coronavirus/2019-ncov/your-health/if-you-were-exposed.html https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

Any individual with probable or confirmed COVID-19, regardless of their vaccination status, must not enter a DOE site/facility or interact with members of the public in person as part of their official DOE responsibilities, consistent with Safer Federal Workforce Task Force and CDC guidance on isolation, and monitor their symptoms.

This includes people who have an initial positive diagnostic viral test for COVID-19, regardless of whether or not they have symptoms, and people with symptoms of COVID-19, including people who are awaiting test results or have not been tested.

To be consistent with Safer Federal Workforce Task Force guidance, individuals who tested positive for COVID-19 and never developed symptoms are allowed to return to working onsite at a DOE site/facility or interacting with members of the public as part of their official DOE responsibilities after 5 full days following their positive COVID-19 test (day 0 being the day the individual was tested).

To be consistent with Safer Federal Workforce Task Force guidance, individuals who tested positive for COVID-19 and had symptoms are allowed to return to working onsite at a DOE site/facility or interacting with members of the public as part of their official DOE responsibilities after 5 full days from the onset of symptoms (day 0 being the day of symptom onset), once they are fever-free for 24 hours without the use of fever- reducing medication and their other symptoms are improving. Note that loss of taste and smell may persist for weeks or months after recovery and need not delay the end of isolation.

If an individual had moderate illness (if they experienced shortness of breath or had difficulty breathing) or severe illness (they were hospitalized) due to COVID-19, or they have a weakened immune system, then to be consistent with Safer Federal Workforce Task Force guidance, the individual should be advised to delay returning to working onsite at a DOE site/facility or interacting with members of the public as part of their official DOE responsibilities for a full 10 days. If an individual had severe illness or has a weakened immune system, they should consult their healthcare provider before ending isolation. If an individual is unsure if their symptoms are moderate or severe or if they have a weakened immune system, the individual should talk to a healthcare provider for further guidance.

To be consistent with Safer Federal Workforce Task Force guidance, DOE sites/facilities should not use a test-based approach to determine when, after having tested positive for COVID-19 and isolated, an individual can return to working onsite at a DOE workplace or interacting with members of the public as part of their official duties, absent an exception approved by the Secretary following consultation with the DOE COVID-19 Coordination Team and the Safer Federal Workforce Task Force.

Once an individual has returned to working onsite at a DOE site/facility or interacting with members of the public as part of their official DOE responsibilities after having tested positive for COVID-19 and isolated consistent with Safer Federal Workforce Task Force and CDC guidance on isolation, then pursuant to EO 13991 and consistent with CDC guidance, the individual must continue to take precautions consistent with CDC guidance for at least 10 full days after their first day of symptoms, or after the date of a positive viral test for asymptomatic individuals, including wearing a “high-quality” mask or respirator (such as an N95) when around others, avoiding eating and drinking around others, avoiding environments such as dining facilities, gyms, or other places where they might need to be unmasked around others, and avoiding being around people who they know are at high risk for severe disease from COVID-19.

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

As it relates to mask-wearing after returning from isolation, individuals can opt to take two viral antigen tests authorized by the FDA to detect current COVID-19 infection, starting as early as day 6. With two sequential negative tests 48 hours apart, the individual may remove their mask sooner than day 10. If either of their antigen test results are positive, the individual should continue taking antigen tests at least 48 hours apart until they have two sequential negative results. This may mean that the individual would continue wearing a mask and testing beyond day 10.

If at any point their COVID-19 symptoms recur or worsen, an individual again may not enter a DOE site/facility or interact with members of the public as part of their official DOE responsibilities, restarting at day 0, consistent with EO 13991 and CDC recommendations on isolation and associated protocols.

Personnel should contact Occupational Medicine (om@ameslab.gov) for additional information.

8.10. Management of On-site COVID-19 Cases

In the event a positive case is identified at Ames Laboratory, the Laboratory will comply with established Iowa Department of Public Health protocols and notification procedures, including notification to DOE, and local or county health officials.

Employees only need to report COVID-19 cases if they have been on-site at a government facility, at a government-sanctioned event, or on official travel within the 10 days prior to onset of symptoms or testing positive or within the 5 days after onset of symptoms. These are cases that may be work-related or may be appropriate for contact tracing or cleaning. Determinations of whether a case is work-related, or whether contact tracing or cleaning are appropriate, will be made at the site level.

Reporting of weekly COVID cases to the DOE COVID-19 Hotline has been paused along with the posting of weekly COVID summary data. All deaths associated with COVID-19 must still be reported to the DOE COVID-19 Hotline within one business day. An anonymized summary narrative will be requested for each death associated with COVID-19. Sites may use the COVID- 19 Hotline’s application to track cases at their site. If/when weekly reporting is resumed, programs and sites will be notified and will follow established protocols for reporting the status of COVID cases to the DOE COVID-19 Hotline (or a field office or agency component designee).

To promote transparency and safety, sites will notify their workforce about confirmed COVID cases, as relevant and appropriate, consistent with local and Federal privacy and confidentiality regulations and laws. Depending on the circumstances and such factors as the size of the site, notifications will be made by contacting individuals or by issuing broader messages.

8.11. Confidentiality

When providing information to the workforce on confirmed COVID-19 cases, the Laboratory must balance the privacy rights of the individual diagnosed with COVID-19 with the need to openly communicate with the workforce. All medical information collected from personnel, including test results and any other information obtained as a result of testing and symptom monitoring, will be treated confidentially in accordance with applicable law, and accessible only by those with a need to know in order to protect the health and safety of personnel. The DOE will direct all questions relating to personal medical data to an appropriate point of contact.

Generally, in accordance with the Rehabilitation Act of 1973, Americans with Disabilities Act, and with privacy laws, managers and supervisors may not specifically disclose the identity of an mailto:om@ameslab.gov

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

individual who has or may have COVID-19 or provide information, such as the specific location of the individual’s workstation, which will allow other employees to identify the individual.

Supervisors may ask the individual for consent to share their identity information with those whom they have been in close contact. Even if an individual provides consent to such disclosure, identifying information is only to be provided to those who have a need to know.

Additionally, managers and supervisors may not specifically disclose the vaccination status of individuals unless there is a need to know. In general, managers and supervisors should make modifications to travel, work schedules, and operations in accordance with CDC and OSHA guidelines without singling out specific individuals. Managers and supervisors should only disseminate information to the appropriate DOE or Laboratory officials who have a need to know to ensure effective implementation of the safety protocols.

9.0 HEALTH AND SAFETY PROTOCOLS – FACILITIES AND OPERATIONS

9.1. Construction Activities

Subcontractors must follow Laboratory protocols based on current COVID-19 Hospital Admission Level.

9.2. Elevators

There is no restriction on elevator usage. Persons are encouraged to physically distance and not overcrowd during periods of MEDIUM or HIGH Levels.

9.3. Emergency Actions

Emergency events most likely to impact Ames Laboratory are evacuations due to fire or chemical spill, or sheltering due to severe weather. Staff are expected to follow evacuation or sheltering procedures.

• Evacuation – staff will exit buildings and gather in a safe area.

• Sheltering – staff will gather in designated shelter areas during a severe weather event.

9.4. Meetings, Events, Conferences, and Travel

9.4.1. Meetings Events and Conferences

Regardless of the Hospital Admission Level, no approval is required if the Laboratory hosts an in-person meeting, conference, or event that will be attended by more than 50 participants.

In-person attendees in areas of HIGH Hospital Admission Levels must wear a high-quality mask in public indoor settings. Regardless of Levels, Ames Laboratory will not collect vaccination information or require proof of negative COVID-19 tests for meeting attendees.

9.4.2. Travel

There are no Government-wide limits on official travel (i.e., travel conducted under an official travel authorization) regardless of an individual’s vaccination status. The Safer Federal Workforce Task Force has issued extensive travel guidance that is located at Travel | Safer Federal Workforce.

Federal and contractor employees, regardless of vaccination status, must utilize the normal DOE travel policies and organizational approval processes for official domestic and international travel. In approving official travel, DOE sites/facilities should:

https://www.saferfederalworkforce.gov/faq/travel/ https://www.saferfederalworkforce.gov/faq/travel/

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

• Inform the traveling individual that CDC recommends that individuals make sure they are up to date with COVID-19 vaccines before travel;

• Recommend that the traveling individual consider being tested for current infection with a viral test as close to the time of departure as possible (no more than 3 days) before travel;

• Instruct the traveling individual to adhere strictly to CDC guidance for domestic and international travel before, during, and after official travel;

• Instruct the traveling individual to check their destination’s COVID-19 Level before 15 | Page traveling, and to wear a high-quality mask or respirator (such as an N95) while on-duty and around others indoors at their destination, if the COVID-19 Level in the county where their destination is located is HIGH;

• Instruct the traveling individual to make sure they understand and follow all travel restrictions put in place by State, Tribal, local, and territorial governments; and

• Advise the traveling individual to prepare to be flexible during their travel, as restrictions, policies, and circumstances may change during their travel.

Travel for Individuals with Known Exposure

For asymptomatic individuals who have had a known exposure to someone with COVID-19 within the past 10 days, DOE sites/facilities may approve official travel consistent with DOE’s travel policies. If the individual remains without COVID-19 symptoms before traveling, then pursuant to EO 13991 and consistent with CDC guidance, the individual must, in addition to other standard pre-travel instructions related to COVID-19:

• Wear a “high-quality” mask or respirator (such as an N95) the entire time they are on-duty and around others indoors for the full duration of their travel that falls within the 10 full days after their last known exposure;

• Not travel on public transportation such as airplanes, buses, and trains if they will not be able to wear a high-quality mask or respirator (such as an N95) when around others indoors for the full duration of their travel within the 10 full days after their last known exposure; and

• Follow other aspects of post-exposure protocols, including the requirement for individuals with a known exposure to be tested for COVID-19 after 5 full days following their last known exposure (ideally, on or after day 6). Please note that this testing may need to occur while the individual is traveling, and that sites/facilities do not need to require that employees wait for the results of this post-exposure diagnostic test to undertake official travel, including return travel.

If the individual develops COVID-19 symptoms after official travel has been approved, then pursuant to EO 13991 and consistent with CDC guidance, the individual must not undertake further official travel, including under a previously approved travel authorization, and instead follow protocols consistent with the Safer Federal Workforce Task Force guidance on travel for individuals with COVID-19 symptoms (see next section).

Travel for Individuals with COVID-19 Symptoms or a Positive COVID-19 Test

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

Pursuant to EO 13991 and consistent with CDC guidance, official travel (i.e., travel conducted under an official travel authorization) may not be approved for individuals who have COVID-19 symptoms and are waiting for an initial diagnostic viral test result, and for individuals who have tested positive for COVID-19 for at least 5 full days after their first day of symptoms or after the date of the initial positive diagnostic viral test for asymptomatic individuals.

If an individual who tested positive for COVID-19 has returned to working onsite at a DOE site/facility or interacting with members of the public as part of their official DOE responsibilities (once they are fever-free for 24 hours without the use of fever-reducing medication and their other symptoms are improving), then official travel may be approved for the individual.

Pursuant to EO 13991 and consistent with CDC guidance, the individual must, in addition to other standard pre-travel instructions related to COVID-19:

• Wear a “high-quality” mask or respirator (such as an N95) the entire time they are on-duty and around others indoors for the full duration of their travel that falls within the period they are otherwise required to wear a high-quality mask or respirator after ending isolation, consistent with Safer Federal Workforce Task Force guidance;

• Not travel on public transportation such as airplanes, buses, and trains if they will not be able to wear a high-quality mask or respirator (such as an N95) when around others for the full duration of their travel that falls within the period they are otherwise required to wear a high-quality mask or respirator after ending isolation, consistent with Safer Federal Workforce Task Force guidance; and

• Follow other aspects of post-isolation protocols.

If after official travel has been approved, the individual’s COVID-19 symptoms recur or worsen, then pursuant to EO 13991 and consistent with CDC guidance on isolation, the individual may not undertake further official travel, including under any previously approved travel authorization, and again may not enter a DOE site/facility or interact with members of the public as part of their official DOE responsibilities, restarting at day 0 of isolation protocols.

Leave Related to Isolation and Travel

Leave related to isolation and travel must be coordinated through the Supervisor and be based on Laboratory and University policy.

9.5. Dining/Vending Area

The dining and vending area is open for use. Staff should clean and disinfect area after use.

Applicable protocols outlined in this document (face masks, social distancing, etc.) must be adhered to while in the dining/vending area.

9.6. Ventilation and Air Filtration

To the maximum extent feasible, and with consideration of current guidance from the CDC, OSHA, and the American Society of Heating, Refrigerating and Air-Conditioning Engineers, indoor ventilation will be optimized to increase the proportion of outdoor ventilation, improve filtration, and reduce or eliminate recirculation. Where technically practicable, and depending on the availability of funds, continued action will be taken to improve engineering controls such as improving Minimum Efficiency Reporting Value (MERV) filter efficiency ratings and sealing of filters. Space heaters, desk fans, and other devices that provide air movement inside a space are

The official version of this document is maintained electronically in ServiceNow. All other copies are considered unofficial and may not be current.

to be eliminated to the extent practicable. If needed, work should be relocated to room/buildings with better ventilation characteristics.

10.0 APPROVAL RECORD

• Reviewed by: Ames Site Office Representative (Joe Nolin)

• Approved by: Assurance Manager (Molly Granseth)

• Approved by: Director Safety and Security (Sean Whalen)

• Approved by: Legal Counsel (Jane Morris)

• Approved by: Chief Operations Officer (Steve Hamilton)

• Approved by: Laboratory Director (Adam Schwartz)

The official approval record for this document is maintained by Document Control.

RESTRICTIVE NOTICE

THE DRAWINGS AND SPECIFICATIONS INCLUDED IN THIS SOLICITATION ARE THE

PROPERTY OF AMES LABORATORY AND MAY ONLY BE FOR THE EXPRESS PURPOSE

OF PREPARING A RESPONSE TO THIS SOLICITATION. FURTHER DISSEMINATION OF

DRAWINGS AND SPECIFICATIONS OTHER THAN TO POTENTIAL INDIVIDUAL

SUBCONTRACTORS AND/OR SUPPLIERS IS PROHIBITED, AND MAY SUBJECT THE

DISSEMINATOR TO CIVIL PENALTIES. THIS NOTICE SHALL BE MADE KNOWN TO AND

BE APPLICABLE TO ALL POTENTIAL INDIVIDUAL SUBCONTRACTORS AND/OR

SUPPLIERS. DRAWINGS AND SPECIFICATIONS MAY NOT BE PLACED ON THE

INTERNET WITHOUT THE PRIOR WRITTEN PERMISSION OF AMES LABORATORY.

Date:7/7/2023

TO: ALL OFFERORS

Subject: Request for Proposal (RFP) A23-1484

Ames Laboratory, under a prime contract with the U.S. Department of Energy (DOE), has a requirement for construction. With this Request for Proposal (RFP), you are invited to furnish a fixed-price proposal for this requirement. All work is to be performed in accordance with the Contractor Requirements , Appendix B.

The Laboratory intends to award one subcontract resulting from this solicitation to that offeror whose offer conforming to the solicitation will be most advantageous to the Laboratory, the best value, price and other factors as specified, considered. Therefore, your firm is invited to submit a proposal for these requirements.

Below is pertinent information regarding this RFP:

Procurement Event

Due date & time

(ALL TIME LISTED ARE

CENTRAL TIME ZONE)

Optional Pre-Proposal Meeting and Site Tour: Location of event is 2408 Pammel Drive, Ames Iowa 50011. Room 205 TASF

7/14/2023 by 10:00 AM

Explanation or Interpretation of Documents: Questions regarding the solicitation shall be submitted via email to the Procurement Agent no later than:

7/19/2023 by 4:00 PM

Proposal Submission Due Date. Proposals shall be submitted via email to the Procurement Agent no later than:

7/28/2023 by 4:00 PM

Anticipated award date of subcontract is: 8/4/2023

UNDER NO CIRCUMSTANCES SHOULD OFFERORS DIRECTLY CONTACT ANYONE OTHER THAN THE

PROCUREMENT AGENT OR HIS/HER DESIGNEE REGARDING THIS SOLICITATION.

For your information and use in preparing this proposal, we are providing you with the following applicable provisions.

Andrew Saxton Purchasing Agent Ames Laboratory 2408 Pammel Dr.

231 TASF

Ames, IA 50011-1015

(515) 294-4191

Ames Laboratory is operated by Iowa State University for the U.S. Department of Energy. Ames, Iowa 50011-3020.

1. DESCRIPTION AND LOCATION OF WORK

Refer to Construction Specifications.

2. NOTICE OF TOTAL SMALL BUSINESS SET ASIDE

a. Definition. (1) “Small Business Concern,” as used in this clause, means a concern, including its affiliates, that is independently owned and operated, not dominant in the field of operation in which it is bidding on Government contracts, and qualified as a small business under the size standards defined in this solicitation. (2) “Offer” includes “Bid.”

b. General. (1) Offers are solicited only from small business concerns. Offers received from concerns that are not small business concerns shall be considered non-responsive and will be rejected. (2) Any award resulting from this solicitation will be made to a small business concern.

3. SMALL BUSINESS SIZE STANDARDS

The applicable annual receipt criterion for a small business concern in this area of general construction is a concern that had average annual receipts for the preceding three (3) years not exceeding $45 Mil (NAICS Code(s)236210).

The table of size standards can also be found online in the small business size regulations set forth in the Electronic Code of Federal Regulations. Offerors can also check whether your business is small using the size standards tool.

PLEASE NOTE: The small business size standard for a concern which submits an offer in its own name, but which proposes to furnish an item which it did not itself manufacture, is 500 employees.

4. PRE-PROPOSAL MEETING (OPTIONAL)

An optional pre-proposal meeting and site tour are scheduled for 10 a.m. CST on 7/14/2023. The meeting provides an opportunity to discuss and clarify this RFP. However, nothing said or represented in the meeting shall be deemed to modify RFP requirements unless followed by a written amendment. Offerors are requested to submit questions relative to the RFP in advance of the meeting so the Laboratory may prepare responses. It is not required for prospective offerors to attend this meeting, but it is encouraged.

5. EXPLANATION OR INTERPRETATION OF RFP DOCUMENTS

Any prospective offeror desiring an explanation or interpretation of the solicitation, drawings, specifications, etc., must be requested via e-mail to saxton@ameslab.gov by 4 p.m. CST on 7/19/2023. Verbal answers are not binding on any party. Any information given a prospective offeror concerning a solicitation will be furnished promptly to all other prospective offerors as an amendment to the solicitation, if that information is necessary in submitting proposals or if the lack of it would be prejudicial to the other prospective offerors.

6. PERIOD OF PERFORMANCE

Work on site will commence as negotiated and after the notice to proceed has been issued. The work will be completed no later than 10/20/2023 unless an extension has been approved by the Ames Laboratory Purchasing Representative.

https://www.ecfr.gov/cgi-bin/text-idx?SID=b919ec8f32159d9edaaa36a7eaf6b695&mc=true&node=pt13.1.121&rgn=div5#se13.1.121_1201 https://www.sba.gov/size-standards

Ames Laboratory is operated by Iowa State University for the U.S. Department of Energy. Ames, Iowa 50011-3020.

7. INSURANCE

Certificates of insurance of the types and in the amounts set forth in “Bonds and Insurance” clause in the enclosed Appendix A, Ames Laboratory Terms and Conditions for Fixed-Price Construction Contracts will be required of you before physical work at the site commences. In accordance with paragraph (g) of “Bonds and Insurance” clause, all policies shall provide by appropriate language that Ames Laboratory, Iowa State University and the United States Government are additional insureds, that the insurance afforded by such policies is primary insurance, and that all rights of the insurer for contribution from other insurers of Ames Laboratory, Iowa State University and the United States Government are waived.

8. SAFETY PERFORMANCE REQUIREMENTS

Offerors and…